Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review | Zendy

Julien Péron | Zendy; Gregory R. Pond | Zendy; Hui Gan | Zendy; Eric X. Chen | Zendy; Ragheed Al-Mufti | Zendy; Denis Maillet | Zendy; Benoît You | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review

Author(s) -

Julien Péron,

Gregory R. Pond,

Hui Gan,

Eric X. Chen,

Ragheed Al-Mufti,

Denis Maillet,

Benoît You

Publication year - 2012

Publication title -

jnci journal of the national cancer institute

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.797

H-Index - 356

eISSN - 1460-2105

pISSN - 0027-8874

DOI - 10.1093/jnci/djs259

Subject(s) - consolidated standards of reporting trials , blinding , medicine , randomized controlled trial , sample size determination , quality score , clinical trial , scale (ratio) , research design , quality (philosophy) , impact factor , family medicine , statistics , metric (unit) , philosophy , operations management , physics , mathematics , epistemology , quantum mechanics , economics , political science , law

The Consolidated Standards of Reporting Trials (CONSORT) guidelines were developed in the mid-1990s for the explicit purpose of improving clinical trial reporting. However, there is little information regarding the adherence to CONSORT guidelines of recent publications of randomized controlled trials (RCTs) in oncology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research